Recent investigations into the UBR5/RORA/SPLUNC1 axis reveal its critical role in amplifying this immunosuppressive cascade, particularly in NPC, where UBR5 silencing attenuates GPR132-mediated M2 macrophage reprogramming and glycolytic flux in preclinical models [57]. Here, UBR5 is linked to nasopharyngeal carcinoma.